Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting scheduled to be held on Friday, November 13, 2026 at 06:00 PM at the registered office of the Company, inter-alia, to consider and approve the Standalone and Consolidated unaudited Financial Results of the Company for the half year ended September 30, 2026

November 09, 2026 Hyderabad Corporate Relations Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001. Sub: Intimation of Board Meeting to be held on November 13, 2026 Ref: Scrip Code: 540729 | Scrip ID: VANTABIO Dear Sir/Madam, Pursuant to provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday, November 13, 2026 at 06:00 PM at the registered of(cid:976)ice of the Company, inter-alia, to consider and approve the Standalone and Consolidated unaudited Financial Results of the Company for the half year ended September 30, 2026 and to take note of the Limited Review Report issued by the Statutory Auditors thereon. In continuation of our previous intimation dated September 29, 2026, the Trading Window for all designated persons as de(cid:976)ined under Insider Trading Policy of the Company is closed from October 01, 2026 till November 15, 2026 (both days inclusive). We request you to kindly take note of the same in your record. Thanking you FOR VANTA BIOSCIENCE LIMITED DOPESH RAJA MULAKALA MANAGING DIRECTOR DIN: 01176660